Today, the safety margin of normal tissue around the tumor absorbs a large portion of the radiation beam, adds Jean-Philippe Pignol, Professor of Radiation Oncology and a key leader on the Elekta partnership at Sunnybrook's Odette Cancer Centre. "The expectation is that MR-guided radiation therapy will enable us to treat more cancer tissue than normal tissue. In doing so, we could apply, in a single fraction, a huge dose to the tumor while avoiding side effects to normal tissues," he says.
"The development of advanced imaging solutions for oncology therapy planning and delivery is a key focus area for Philips," says Gene Saragnese, CEO Imaging Systems at Philips Healthcare. "Philips is already closely working together with Sunnybrook Health Sciences Centre in this field, and we welcome their expertise to the research consortium for MR guided radiotherapy. The members will jointly work on the design and implementation of the clinical studies with the objective of bringing image-guided oncology therapy to the next level, and ultimately creating the future of healthcare."
The integrated MRI-guided radiation therapy system is in development and not available for sale.
For further information, please contact: Johan Andersson, Director, Investor Relations, Elekta AB Tel: +46 702 100 451, email: firstname.lastname@example.org Time zone: CET: Central European TimeMichelle Joiner, Director, Global Public Relations and Brand Management, Elekta Tel: +1 770-670-2447, email: email@example.com Time zone: ET: Eastern Time Steve Klink, Philips Corporate Communications Tel: +31 20 5977415, email: firstname.lastname@example.org About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com. About Royal Philips Electronics Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter. SOURCE Elekta
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts